硕世生物(股票代码:688399.SH),聚焦「传染病检测」和「妇幼健康」两大领域,是分子诊断行业的创新领导者之一。 自2010年创立以来,始终致力于体外诊断试剂、仪器的研发、生产、销售与整体解决方案的提供,并逐步构建自上游核心原料贯穿至下游检验服务的一体化布局,逾700种产品广泛服务于全球100多个国家和地区的医疗机构、疾控中心及第三方医学检验实验室。 目前,公司已在分子诊断主营优势持续巩固的情况下,在POCT等高增速细分领域稳步发力,拓宽应用场景,完善产品矩阵,同时积极布局海外市场,打造具有国际竞争力的全球化品牌,以期早日实现「在全球诊断行业占有一席之地」之愿景。在「为健康」的使命驱动下,以精准、快速、简便的创新诊断技术,探索传染病和重大疾病的早筛早诊模式,提升生命质量,造福人类健康。
If you are interested in booking a stand at CACLP, please leave your details below and one of our representatives will be in touch soon.
Copyright © 2026 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.